The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 03, 2023

Filed:

May. 18, 2020
Applicants:

Arizona Board of Regents on Behalf of the University of Arizona, Tucson, AZ (US);

The Texas A&m University System, College Station, TX (US);

Inventors:

Victor J. Hruby, Tucson, AZ (US);

Minying Cai, Tucson, AZ (US);

Caurnel Morgan, College Station, TX (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/12 (2006.01); A61K 38/34 (2006.01); C07K 14/68 (2006.01); A61K 38/00 (2006.01); A61P 25/18 (2006.01); A61P 25/22 (2006.01); A61P 25/24 (2006.01); A61K 38/08 (2019.01); A61K 38/06 (2006.01); A61K 38/07 (2006.01); C07K 5/02 (2006.01); A61K 9/00 (2006.01); A61K 9/70 (2006.01);
U.S. Cl.
CPC ...
C07K 5/0202 (2013.01); A61K 9/0019 (2013.01); A61K 9/0053 (2013.01); A61K 9/7023 (2013.01); A61K 38/07 (2013.01); A61K 38/12 (2013.01); A61P 25/22 (2018.01); A61P 25/24 (2018.01); A61K 38/00 (2013.01);
Abstract

Compositions and methods for treating a depressive disorder or an anxiety disorder in a subject in need of such treatment are described herein. A therapeutically effective amount of a composition comprising a melanocortin 5 receptor (MC5R) peptide ligand according to the following: in a pharmaceutically acceptable carrier is administered to the subject. Xaa can be Cha or Pro. The MC5R peptide is a selective MC5R antagonist, and administration thereof to the subject can treat the depressive or anxiety disorder with clinical improvement observed in a relatively short time.


Find Patent Forward Citations

Hruby, Victor. (2023). Modulators of melanocortin receptors for the treatment of depression and anxiety (U.S. Patent No. 11542302). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/11542302

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…